ST. LOUIS (Dec. 8, 2015) – In July, Monsanto retained Intertek Scientific & Regulatory Consultancy to convene an expert panel to review the International Agency for Research on Cancer (IARC) monograph on glyphosate. The international experts recently completed their evaluation of the IARC monograph on glyphosate and presented their findings during a poster session at the annual meeting of the Society for Risk Assessment (SRA).
In a presentation abstract, the experts concluded, “None of the results from a very large database, using different methodologies, provides evidence of, or a potential mechanism for, human carcinogenesis.” The expert panel also found that the IARC animal bioassay and genotoxicity evaluations “suffered from significant weaknesses such as: selectivity in the choice of data reviewed, failure to use all relevant biologic information to evaluate relationship to treatment in animal bioassays, and failure to use weight-of-evidence (WOE) evaluations using all available data and appropriate weighting.” The full abstract is posted here.
The panel’s findings are consistent with the recent European Food Safety Authority’s (EFSA) conclusion that “glyphosate is unlikely to pose a carcinogenic hazard to humans”; the determination of the Canadian Pest Management Regulatory Agency in April that “the overall weight of evidence indicates that glyphosate is unlikely to pose a human cancer risk”; and a recent statement from the U.S. EPA that a set of 55 epidemiological studies “does not provide evidence to show that glyphosate causes cancer.”
For more information about the expert panel and its members, please click here.
About Monsanto Company
Monsanto is committed to bringing a broad range of solutions to help nourish our growing world. We produce seeds for fruits, vegetables and key crops – such as corn, soybeans, and cotton – that help farmers have better harvests while using water and other important resources more efficiently. We work to find sustainable solutions for soil health, help farmers use data to improve farming practices and conserve natural resources, and provide crop protection products to minimize damage from pests and disease. Through programs and partnerships, we collaborate with farmers, researchers, nonprofit organizations, universities and others to help tackle some of the world’s biggest challenges. To learn more about Monsanto, our commitments and our more than 20,000 dedicated employees, please visit: discover.monsanto.com and monsanto.com. Follow our business on Twitter® at twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at monsantoblog.com or subscribe to our News Release RSS Feed.
About Monsanto Caribe
Since 1996, Monsanto Caribe LLC has been part of the Puerto Rican seed breeding industry, using the tools of modern biology to help farmers successfully feed, clothe and fuel our growing world. Monsanto’s operations on the island consist of agricultural biotechnology research and development of the best corn, cotton and soy seeds for farmers. The objective is to find the most desirable traits to improve crops and develop new seed with such traits. In Puerto Rico, the company has earned such honors as the 2012, 2013, 2014 and 2015 Los Mejores Patronos en Puerto Rico Award in the Medium Business Category, as well as being inducted in the Puerto Rican Agriculture Hall of Fame in April of 2013. To learn more about our business and our commitments, please visit: www.monsanto.com. Follow our business on Twitter® at www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows at www.monsantoblog.com, or subscribe to our News Release RSS Feed. For information in Spanish, please visit www.monsanto.pr, and follow our business on Facebook® at facebook.com/monsantopuertorico.